Warren Viricel

Warren Viricel has a diverse work experience in the pharmaceutical and bioscience industries. Warren co-founded Mablink Bioscience in 2018 and currently serves as the Chief Scientific Officer. Prior to this, they founded Lina Therapeutics in 2017 and held the position until 2018. Warren obtained a PhD in Pharmaceutical Sciences with a focus on Pharmaceutical Engineering from Université de Montréal from 2012 to 2016. Warren also holds a PharmD degree from Université Claude Bernard Lyon 1, which they completed from 2006 to 2013.

Warren Viricel completed their education in a chronological manner as follows:

- From 2012 to 2016, they attended Université de Montréal, where they obtained a PhD in Pharmaceutical Sciences, focusing on Pharmaceutical Engineering.

- Between 2007 and 2013, they studied at Université Claude Bernard Lyon 1 and earned a Diplôme d'Etat de Docteur en Pharmacie (PharmD), specializing in Pharmacy.

- In 2011 and 2012, they pursued a Master 2 degree in Sciences du médicament at Université Claude Bernard Lyon 1.